Table 3.
Summary pharmacokinetics of R- and S-warfarin (n = 12 subjects).
| LSM entacapone | LSM placebo | Ratio entacapone/placebo(90% CI) | |
|---|---|---|---|
| R-warfarin | |||
| Cmax (µg ml−1) | 0.50 | 0.46 | 109 (102, 117) |
| tmax (h)a | 1.0 | 1.0 | +0.38b (0.00, 0.75) |
| AUCss (µg ml−1 h) | 8.30 | 7.02 | 118 (111, 126) |
| S-warfarin | |||
| Cmax (µg ml−1) | 0.61 | 0.60 | 102 (95, 109) |
| tmax (h)a | 1.0 | 1.0 | +0.25b (−0.25, + 0.50) |
| AUCss (µg ml−1 h) | 10.9 | 10.4 | 105 (99, 110) |
LSM = least squares means
= median value
= difference.